Abstract
Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. To assess the diagnostic accuracy of potential screening tests for the detection of atypical hyperplasia (pre-cancer) and endometrial cancer of all stages and grades in asymptomatic (healthy) women in the general population. Secondary objectives To determine the optimal endometrial thickness cut-off value using transvaginal ultrasound scan for the screening of asymptomatic women for endometrial cancer and atypical hyperplasia. To investigate sources of heterogeneity in endometrial cancer screening studies, including: characteristics of the studied population including age, menopausal status (pre- and postmenopausal), country of study and risk status (body mass index (BMI) categories, diabetes mellitus, polycystic ovary syndrome (PCOS)); characteristics of index test such as cytological classification used and sampling device; methodological quality (low risk of bias compared to high risk of bias); disease factors (endometrioid versus non-endometrioid, low grade versus high grade).
Cite
CITATION STYLE
Njoku, K., O’Flynn, H., Jones, E., Ramchander, N. C., White, H., Macey, R., & Crosbie, E. J. (2021). Screening tests for endometrial cancer in the general population. Cochrane Database of Systematic Reviews, 2021(1). https://doi.org/10.1002/14651858.CD013859
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.